bioRxivImmunologyPreprint
CITEseq analysis of non-small-cell lung cancer lesions reveals an axis of immune cell activation associated with tumor antigen load and TP53 mutations
A. M. Leader, J. A. Grout, C. Chang, B. Maier, A. Tabachnikova, L. Walker, A. Lansky, J. LeBerichel, N. Malissen, M. Davila, J. Martin, G. Magri, K. Tuballes, Z. Zhoa, F. Petralia, R. Samstein, N. R. D'Amore, G. Thurston, A. Kamphorst, A. Wolf, R. Flores, P. Wang, M. B. Beasley, H. Salmon, A. H. Rahman, , M. Merad
Abstract
Immunotherapy is becoming a mainstay in the treatment of NSCLC. While tumor mutational burden (TMB) has been shown to correlate with response to immunotherapy, little is known about the relation of the baseline immune response with the tumor genotype. Here, we profiled 35 early stage NSCLC lesions using multiscale single cell sequencing. Unsupervised clustering identified in a subset of patients a key cellular module consisting of PDCD1+ CXCL13+ activated T cells, IgG+ plasma cells, and SPP1+ macrophages, referred to as the lung cancer activation module (LCAMhi). Transcriptional data from two NSCLC cohorts confirmed a subset of patients with LCAMhi enrichment, which was independent of overall immune cell content. The LCAMhi module strongly correlated with TMB, expression of cancer testis antigens, and with TP53 mutations in smokers and non-smokers. These data establish LCAM as a key mode of immune cell activation associated with high tumor antigen load and driver mutations.
- organism: human
- assay: CITE-seq
- research focus: cell type annotation
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: deep learning
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- TCR clonality and TCR clonal expansion in the in situ microenvironment of non-small cell lung cancer
Hui Yu, Anastasia Magoulopoulou, … Patrick Micke·Journal for ImmunoTherapy of CancerPeer-reviewed·Aug 1, 2025
- Single-Cell Map of Diverse Immune Phenotypes in the Metastatic Brain Tumor Microenvironment of Non Small Cell Lung Cancer
- Increased inflammatory signature in myeloid cells of non-small cell lung cancer patients with high clonal hematopoiesis burden
Hyungtai Sim, Hyun Jung Park, … Murim Choi·eLifePeer-reviewed·Nov 20, 2024
- Polyfunctional tumor-reactive T cells are effectively expanded from non-small cell lung cancers, and correlate with an immune-engaged T cell profile
R. de Groot, M. M. van Loenen, … M. C. Wolkers·bioRxiv·Jun 8, 2019
- Acquired resistance to anti-PD1 therapy in patients with NSCLC reveals changes in T cell phenotypes and MET amplification
S. Hiltbrunner, L. Cords, … A. Curioni-Fontecedro·bioRxiv·Apr 8, 2022
- Integrative Analysis of Checkpoint Blockade Response in Advanced Non-Small Cell Lung Cancer
Arvind Ravi, Justin F. Gainor, … Matthew David Hellmann·bioRxiv·Mar 21, 2022